KLYG — Kelyniam Global Income Statement
0.000.00%
HealthcareSpeculativeMicro Cap
- $5.67m
- $5.96m
- $0.20m
Annual income statement for Kelyniam Global, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2006 December 31st | 2007 December 31st | 2008 December 31st | 2009 December 31st | 2010 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10KSB | 10KSB | ARS | ARS | ARS |
Standards: | USG | USG | — | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.069 | 0.047 | 0.451 | 0.273 | 0.201 |
Cost of Revenue | |||||
Gross Profit | 0.069 | -0.053 | 0.302 | 0.17 | 0.084 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 0.079 | 0.22 | 0.658 | 0.47 | 0.441 |
Operating Profit | -0.01 | -0.173 | -0.207 | -0.197 | -0.24 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.045 | -0.182 | -0.221 | -0.215 | -0.257 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.045 | -0.182 | -0.221 | -0.215 | -0.257 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.045 | -0.182 | -0.221 | -0.215 | -0.257 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.045 | -0.182 | -0.221 | -0.215 | -0.257 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.003 | -0.011 | -0.011 | -0.017 | -0.02 |
Dividends per Share |